Thiotepa (Shorla Oncology)

塞替派 (Shorla Oncology)

Report date: 2025/05/12 15:27:13

Base Information

Drug NameThiotepa (Shorla Oncology)
Drug Alias NameTEPYLUTESH-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsAlkylating agents
TargetsDNA
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsOvarian NeoplasmsBreast Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/06/25
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShorla Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShorla Oncology IncShorla Pharma Ltd
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A